Beck Bode’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BBIO
Beck Bode's BBIO Position: Q4 2024 in Review
Beck Bode sold out of BridgeBio Pharma (BBIO) in Q4 2024, closing a stake of 410,531 shares — an estimated $10.5M sold.
Beck Bode first reported a position in BBIO in Q3 2024 and held it in 1 quarter. The position peaked at $10.5M in Q3 2024. 263 funds tracked by Wall St. Rank hold BBIO as of Q4 2024.
- Beck Bode reported no remaining BridgeBio Pharma position as of Q4 2024 after selling out during the quarter.
- Beck Bode sold 410,531 BridgeBio Pharma shares in Q4 2024, an estimated $10.5M.
- Beck Bode first reported a position in BridgeBio Pharma in Q3 2024 and held it in 1 quarter.
- Beck Bode's BridgeBio Pharma position peaked at $10.5M in Q3 2024.
- 263 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q4 2024.
Based on Beck Bode's 13F filing for Q4 2024, filed 14 Feb 2025.